SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 8-K - Current report:
SEC Accession No. 0001213900-22-000259
Filing Date
2022-01-03
Accepted
2022-01-03 16:20:53
Documents
14
Period of Report
2021-12-27
Items
Item 1.01: Entry into a Material Definitive Agreement
Item 3.02: Unregistered Sales of Equity Securities
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq Description Document Type Size
1 CURRENT REPORT ea153369-8k_bespokeext.htm   iXBRL 8-K 25006
2 FORM OF PURCHASE AGREEMENT ea153369ex10-1_bespokeext.htm EX-10.1 62698
3 FORM OF WARRANT ea153369ex10-2_bespokeext.htm EX-10.2 35635
  Complete submission text file 0001213900-22-000259.txt   315284

Data Files

Seq Description Document Type Size
4 XBRL LABEL FILE bspk-20211227_lab.xml EX-101.LAB 34240
5 XBRL PRESENTATION FILE bspk-20211227_pre.xml EX-101.PRE 22373
6 XBRL SCHEMA FILE bspk-20211227.xsd EX-101.SCH 3046
8 EXTRACTED XBRL INSTANCE DOCUMENT ea153369-8k_bespokeext_htm.xml XML 3268
Mailing Address 2590 WALNUT ST. DENVER CO 80205
Business Address 2590 WALNUT ST. DENVER CO 80205 855-633-3738
Bespoke Extracts, Inc. (Filer) CIK: 0001409197 (see all company filings)

IRS No.: 204743354 | State of Incorp.: NV | Fiscal Year End: 0831
Type: 8-K | Act: 34 | File No.: 000-52759 | Film No.: 22502391
SIC: 2834 Pharmaceutical Preparations